JAZZ FY 2018 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.9B+16.8% YoY

Gross Profit

$1.8B93.6% margin

Operating Income

$615M32.5% margin

Net Income

$447M23.6% margin

EPS (Diluted)

$7.30

Cash Flow

Operating Cash Flow

$799M

Free Cash Flow

$667M

Stock-Based Comp.

$102M

Balance Sheet

Total Assets

$5.2B

Total Liabilities

$2.4B

Stockholders' Equity

$2.8B

Cash & Equivalents

$310M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.9B	$1.6B	+16.8%
Gross Profit	$1.8B	$1.5B	+17.3%
Operating Income	$615M	$529M	+16.3%
Net Income	$447M	$488M	-8.4%